Abstract:Background Phthalate exposure in pregnancy is typically estimated using maternal urinary phthalate metabolite levels. Our aim was to evaluate the association of urinary and placental tissue phthalates, and to explore the role of maternal and pregnancy characteristics that may bias estimates. Methods Fifty pregnancies were selected from the CANDLE Study, recruited from 2006 to 2011 in Tennessee. Linear models were used to estimate associations of urinary phthalates (2(nd), 3(rd) trimesters) and placental tissue phthalates (birth). Potential confounders and modifiers were evaluated in categories: temporality (time between urine and placenta sample), fetal sex, demographics, social advantage, reproductive history, medication use, nutrition and adiposity. Molar and quantile normalized phthalates were calculated to facilitate comparison of placental and urinary levels. Results Metabolites detectable in >80% of both urine and placental samples were MEP, MnBP, MBzP, MECPP, MEOHP, MEHHP, and MEHP. MEP was most abundant in urine (geometric mean [GM] 7.00 x10(2) nmol/l) and in placental tissue (GM 2.56 x10(4) nmol/l). MEHP was the least abundant in urine (GM 5.32 x10(1) nmol/l) and second most abundant in placental tissue (2.04 x10(4) nmol/l). In aggregate, MEHP differed the most between urine and placenta (2.21 log units), and MEHHP differed the least (0.07 log units). MECPP was positively associated between urine and placenta (regression coefficient: 0.31 95% CI 0.09, 0.53). Other urine-placenta metabolite associations were modified by measures of social advantage, reproductive history, medication use, and adiposity. Conclusion Phthalates were ubiquitous in 50 full-term placental samples, as has already been shown in maternal urine. MEP and MEHP were the most abundant. Measurement and comparison of urinary and placental phthalates can advance knowledge on phthalate toxicity in pregnancy and provide insight into the validity and accuracy of relying on maternal urinary concentrations to estimate placental exposures. Impact statement This is the first report of correlations/associations of urinary and placental tissue phthalates in human pregnancy. Epidemiologists have relied exclusively on maternal urinary phthalate metabolite concentrations to assess exposures in pregnant women and risk to their fetuses. Even though it has not yet been confirmed empirically, it is widely assumed that urinary concentrations are strongly and positively correlated with placental and fetal levels. Our data suggest that may not be the case, and these associations may vary by phthalate metabolite and associations may be modified by measures of social advantage, reproductive history, medication use, and adiposity.

Distribution of Phthalate Metabolites Between Paired Maternal-Fetal Samples.

Distribution characteristics of phthalate metabolites in placenta from pregnant women in Tianjin

Phthalate metabolites in meconium and their associations with hormones in cord blood

Free and Total Urinary Phthalate Metabolite Concentrations among Pregnant Women from the Healthy Baby Cohort (hbc), China

Factors Associated with Internal Phthalate Exposure among Pregnant Women

Phthalate Metabolites in Breast Milk from Mothers in Southern China: Occurrence, Temporal Trends, Daily Intake, and Risk Assessment

Phthalate metabolites: Characterization, toxicities, global distribution, and exposure assessment

Assessment on cumulative health risk of phthalic acid esters in meconium of 237 Shanghai newborns

A Study on the Association of Placental and Maternal Urinary Phthalate Metabolites.

Phthalate Esters Levels in Umbilical Cord Blood and Related Factors

Levels of Phthalate Metabolites in Urine of Pregnant Women and Risk of Clinical Pregnancy Loss

Variations of Phthalate Exposure and Metabolism over Three Trimesters.

Association Between Prenatal Phthalate Exposure and Birth Outcomes

Neonatal Phthalate Ester Exposure Induced Placental MTs, FATP1 and HFABP Mrna Expression in Two Districts of Southeast China.

Association between phthalate metabolite mixture in neonatal cord serum and birth outcomes

Effect of exposure to typical phthalate esters on estrogen homeostasis during pregnancy

Phthalate Esters in Biota, Air and Water in an Agricultural Area of Western China, with Emphasis on Bioaccumulation and Human Exposure.

[Cumulative Risk Assessment of Phthalates Exposure among Infants and Their Mothers in Shanghai].

Organophosphate ester and phthalate ester metabolites in urine from primiparas in Shenzhen, China: Implications for health risks

Relationship of individual and mixed prenatal phthalate exposure with placental structure and efficiency in the prospective Ma'anshan Birth Cohort Study

National-scale Urinary Phthalate Metabolites in the General Urban Residents Involving 26 Provincial Capital Cities in China and the Influencing Factors As Well As Non-Carcinogenic Risks